Evidence map›Paper›PMID 41592222›Full record

ArticleJournal of medical Internet research2026

The Phases of Living Evidence Synthesis Using AI AI: Living Evidence Synthesis (Version 1).

Xuping Song, Zhenjie Lian, Rui Wang, Ruixin Li, Zhenzhen Yang, Xufei Luo, Lei Feng, Zhiming Ma, Zhen Pu, Qi Wang and 5 more

Abstract readEvidence Synthesis
In one paragraph

Article in Journal of medical Internet research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xuping SongSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0000-0002-4518-4945
Zhenjie LianSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0009-0008-9867-4578
Rui WangThe Centre of Evidence-based Social Science, Lanzhou University, Lanzhou, Gansu, China.ORCID http://orcid.org/0000-0002-4943-7911
Ruixin LiSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0009-0009-6246-7304
Zhenzhen YangSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0009-0001-2233-6635
Xufei LuoWHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou, Gansu, China.ORCID http://orcid.org/0000-0003-0811-6326
Lei FengSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0009-0000-0556-4444
Zhiming MaSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0009-0002-1288-6657
Zhen PuSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0009-0006-6764-294X
Qi WangSchool of Public Health, University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0002-5060-5978
Long GeSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0000-0002-3555-1107
Caihong LiSchool of Information Science and Engineering, Lanzhou University, Lanzhou, Gansu, China.ORCID http://orcid.org/0009-0000-2127-2759
Yaolong ChenSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0000-0002-7338-4418
Kehu YangSchool of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077.ORCID http://orcid.org/0000-0001-7864-3012
John LavisDepartment of Health Research Methods, Evidence, and Impact, McMaster Health Forum, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0001-7917-3657

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Living evidence (LE) synthesis refers to the method of continuously updating systematic evidence reviews to incorporate new evidence. It has emerged to address the limitations of the traditional systematic review process, particularly the absence of or delays in publication updates. The emergence of COVID-19 accelerated the progress in the field of LE synthesis, and currently, the applications of artificial intelligence (AI) in LE synthesis are expanding rapidly. However, in which phases of LE synthesis should AI be used remains an unanswered question. Objective: This study aims to (1) document the phases of LE synthesis where AI is used and (2) investigate whether AI improves the efficiency, accuracy, or utility of LE synthesis. Methods: We searched Web of Science, PubMed, the Cochrane Library, Epistemonikos, the Campbell Library, IEEE Xplore, medRxiv, COVID-19 Evidence Network to support Decision-making, and McMaster Health Forum. We used Covidence to facilitate the monthly screening and extraction processes to maintain the LE synthesis process. Studies that used or developed AI or semiautomated tools in the phases of LE synthesis were included. Results: A total of 24 studies were included, including 17 on LE syntheses, with 4 involving tool development, and 7 on living meta-analyses, with 3 involving tool development. First, a total of 34 AI or semiautomated tools were involved, comprising 12 AI tools and 22 semiautomated tools. The most frequently used AI or semiautomated tools were machine learning classifiers (n=5) and the Living Interactive Evidence synthesis platform (n=3). Second, 20 AI or semiautomated tools were used for the data extraction or collection and risk of bias assessment phase, and only 1 AI tool was used for the publication update phase. Third, 3 studies demonstrated the improvement in efficiency achieved based on time, workload, and conflict rate metrics. Nine studies applied AI or semiautomated tools in LE synthesis, obtaining a mean recall rate of 96.24%, and 6 studies achieved a mean F1-score of 92.17%. Additionally, 8 studies reported precision values ranging from 0.2% to 100%. Conclusions: AI and semiautomated tools primarily facilitate data extraction or collection and risk of bias assessment. The use of AI or semiautomated tools in LE synthesis improves efficiency, leading to high accuracy, recall, and F1-scores, while precision varies across tools.

Indexed as

Artificial IntelligenceCOVID-19HumansSARS-CoV-2accuracyartificial intelligenceefficiencyliving evidence synthesisphasessemiautomated toolsutility

Identifiers

PMID41592222
PMCPMC12842881

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.